Find Ferric Citrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Iron(iii) citrate, Iron citrate, 3522-50-7, Zerenex, 6043-74-9, 28633-45-6
Molecular Formula
C6H5FeO7
Molecular Weight
244.94  g/mol
InChI Key
NPFOYSMITVOQOS-UHFFFAOYSA-K
FDA UNII
63G354M39Z

Ferric Citrate
1 2D Structure

Ferric Citrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-hydroxypropane-1,2,3-tricarboxylate;iron(3+)
2.1.2 InChI
InChI=1S/C6H8O7.Fe/c7-3(8)1-6(13,5(11)12)2-4(9)10;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);/q;+3/p-3
2.1.3 InChI Key
NPFOYSMITVOQOS-UHFFFAOYSA-K
2.1.4 Canonical SMILES
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Fe+3]
2.2 Other Identifiers
2.2.1 UNII
63G354M39Z
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ferric Citrate Anhydrous

2. Ferric Citrate Dihydrate

3. Ferric Citrate Hydrate

4. Ferric Citrate Iron(+3) Salt

5. Ferric Citrate Trihydrate

6. Ferric Citrate, 59fe-labeled Cpd

7. Ferric Citrate, Iron Salt, 59fe-labeled Cpd

8. Ferric-citric Acid

9. Iron(iii) Citrate

10. Jtt-751

11. Zerenex

2.3.2 Depositor-Supplied Synonyms

1. Iron(iii) Citrate

2. Iron Citrate

3. 3522-50-7

4. Zerenex

5. 6043-74-9

6. 28633-45-6

7. Citric Acid, Iron(3+) Salt

8. Ferrum Citricum

9. Ferriccitrate

10. Iron(iii) Citrate Tribasic

11. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Iron(3+) Salt (1:1)

12. Ferric Citrate Anhydrous

13. Krx-0502

14. Iron(iii)citrate

15. Iron Citrate, Fec6h5o7

16. Auryxia

17. Iron(3+) Citrate

18. 63g354m39z

19. 2338-05-8

20. Iron, (hydrogen Citrato(3-))-

21. Citric Acid, Iron(3+) Salt (1:1)

22. Ferrous Citrate

23. Iron(iii) 2-hydroxypropane-1,2,3-tricarboxylate

24. 2-hydroxy-1,2,3-propanetricarboxylic Acid Iron Salt

25. Ferric Citrate [usan]

26. Ferric Citrate Tetrahydrate

27. Jtt-751

28. Ferric Citrate (van)

29. 2-hydroxypropane-1,2,3-tricarboxylate;iron(3+)

30. Nsc-112227

31. Fexeric

32. Iron(3+) 2-hydroxypropane-1,2,3-tricarboxylate

33. Unii-63g354m39z

34. Jtt 751

35. Fe(iii)-citrate Complex (1:1)

36. Einecs 222-536-6

37. Einecs 249-117-0

38. Iron(iii)-citrate

39. Iron (iii) Citrate

40. Nsc 112227

41. Citric Acid, Iron Salt

42. 1185-57-5

43. Citric Acid,iron(3+)salt

44. Ferric Citrate [mi]

45. Schembl42945

46. Ferric Citrate [fcc]

47. 2-hydroxypropane-1,2,3-tricarboxylate; Iron(3+)

48. Ferric Citrate [inci]

49. Ferrum Citricum [hpus]

50. Ccris 6843

51. Dtxsid0037657

52. Ferric Citrate [who-dd]

53. Iron(iii) Citrate;iron Citrate

54. Hy-n1428c

55. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Iron(3+) Salt

56. Bcp30645

57. Ferric Citrate [orange Book]

58. Akos015918266

59. Db09162

60. Db-119245

61. Cs-0030977

62. Ft-0626407

63. Ft-0627304

64. Ft-0652224

65. Iron 2-hydroxy-1,2,3-propanetricarboxylate

66. A832727

67. Iron(3+); 2-oxidanylpropane-1,2,3-tricarboxylate

68. Q15628111

69. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Iron Salt (1:?)

70. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Iron(2+) Salt (2:3)

2.4 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 244.94 g/mol
Molecular Formula C6H5FeO7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count2
Exact Mass244.938463 g/mol
Monoisotopic Mass244.938463 g/mol
Topological Polar Surface Area141 Ų
Heavy Atom Count14
Formal Charge0
Complexity211
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameFerric citrate
PubMed HealthFerric Citrate (Oral route)
Drug ClassesPhosphate Binder
Drug LabelFerric Citrate is known chemically as iron (+3), x (1, 2, 3-propanetricarboxylic acid, 2 hydroxy-), y (H2O)Ferric Citrate 210 mg ferric iron tablets, equivalent to 1g ferric citrate, are film-coated, peach-colored, and oval-shaped tablets embossed wi...
Active IngredientFerric citrate
Dosage FormTablet
RouteOral
Strength210mg
Market StatusPrescription
CompanyKeryx Biopharma

2 of 2  
Drug NameFerric citrate
PubMed HealthFerric Citrate (Oral route)
Drug ClassesPhosphate Binder
Drug LabelFerric Citrate is known chemically as iron (+3), x (1, 2, 3-propanetricarboxylic acid, 2 hydroxy-), y (H2O)Ferric Citrate 210 mg ferric iron tablets, equivalent to 1g ferric citrate, are film-coated, peach-colored, and oval-shaped tablets embossed wi...
Active IngredientFerric citrate
Dosage FormTablet
RouteOral
Strength210mg
Market StatusPrescription
CompanyKeryx Biopharma

4.2 Therapeutic Uses

Source of iron in treating iron-deficiency anemias. It is less constipating than inorg forms of iron. It is free from astringent & irritant properties. However, ferric ion is less well absorbed than ferrous ion, so that its supposed advantages are outweighed by its lesser efficacy, and it is considered to be an obsolete preparation. In the forms presently marketed, a unit dose provides only the recommended daily allowance of iron (15 mg). /former use/

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 777


VET: Used in prevention & treatment of anemias. Oral biololgy availabilities in rats and chicks have been reported as 107 and 115% respectively, compared to ferrous sulfate. Counteracts oral poisonous effects of gossypol (in cottonseed meal) in poultry trials. Used in wide variety of oral and parenteral hematinics.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 216


Hematinic

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 90


VET: In iron deficiency anemia.

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 90


For more Therapeutic Uses (Complete) data for FERRIC AMMONIUM CITRATE (6 total), please visit the HSDB record page.


Hematinic

O'Neil, M.J. (ed.). The Merck Index - An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th Edition, Whitehouse Station, NJ: Merck and Co., Inc., 2001., p. 716


The in vitro and in vivo availability of iron from total parenteral nutrition solutions to which ferrous citrate has been added was investigated. In vitro experiments showed that 74% of the added iron was available to transferrin. In 7 patients in whom in vivo availability was tested by red cell incorporation, the mean availability was 81%. It was concluded that ferrous citrate is a safe and effective means of iron supplementation in patients on TPN therapy.

Sayers MH et al. JPEN J Parenter Enteral Nutr 7 (2): 117-20 (1983)


4.3 Drug Indication

Fexeric is indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease (CKD).


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Iron [CS]
5.2 ATC Code

V03AE


V - Various

V03 - All other therapeutic products

V03A - All other therapeutic products

V03AE - Drugs for treatment of hyperkalemia and hyperphosphatemia

V03AE08 - Ferric citrate


5.3 Absorption, Distribution and Excretion

The absorption and endogenous excretion of iron in man was studied by monitoring the fecal excretion of a stable iron isotope (58Fe). The study was carried out for 12 healthy volunteers who were divided into two groups. Group I received 58Fe-labeled ferric ammonium citrate (III) (58FeAC) equivalent to 6 mg of iron as a control, and group II received a combination of 500 mg of vitamin C and 58FeAC. A new formula was used to calculate the 58Fe absorption ratio reflecting the pool of iron in the intestinal cells, and the ratio was compared with that obtained from Janghorbani's formula, which has been used as one of the common methods. As a result, the 58Fe absorption ratio in group II was statistically significantly higher than that of group I (34.4 +/- 6.1% vs. 15.0 +/- 5.5%, M +/- SD) using Janghorbani's formula. The similar absorption ratio (34.1 +/- 6.0% vs. 14.8 +/- 5.5%) was also obtained by our new formula. Our results confirmed the previous findings that the availability of iron is stimulated by the supplementation of vitamin C. Both formulae agreed in the absorption of iron, indicating that the endogenous excretion of iron (caused by the desquamated cells) in the intestine does not disguise the iron absorption.

PMID:1294703 Hashimoto F et al; J Nutr Sci Vitaminol (Tokyo) 38 (5): 435-49 (1992)


The absorption of a commercial brand of small-particle reduced iron was evaluated in 10 normal subjects. For each subject, the hemoglobin incorporation method was used to measure the true absorption of 60 mg of iron from either ferrous sulfate or ferric ammonium citrate. The iron tolerance test (ITT) was also studied for these two compounds and for reduced iron. This procedure consisted of measuring the area under the curve of plasma iron elevations at specified times for 6 hours, or the peak plasma iron, corrected by the plasma iron disappearance rate obtained from measuring plasma iron at specified times for 4 hours after the slow intravenous injection of 0.4 mg of iron as ferric citrate. Only the ITT was used to measure the absorption of 60 mg of reduced iron. Reference dose iron ascorbate absorption was measured in each subject. The absorption of ferric ammonium citrate and reduced iron was expressed as percent of dose and also as absorption percent of that of ferrous sulfate. Mean % geometric "true absorptions" were 39.0 for reference dose, 10.4 for FeSO4 and 2.4 for ferric ammonium citrate. The later was 23% that of FeSO4. By ITT the mean geometric % absorptions were 7.9, 3.7 and 3.2 for FeSO4, ferric ammonium citrate and reduced iron respectively, or 47 and 41% of that of FeSO4. We propose that the true absorption of the commercial brand of reduced iron tested was 20% that of FeSO4 based on the relation between the ITT results of reduced iron and the ITT and true absorption values of ferric ammonium citrate in relation to FeSO4.

PMID:11791474 Gonzalez H et al; Arch Latinoam Nutr 51 (3): 217-24 (2001)


Gastrointestinal absorption of iron is adequate ... /yet/ ... lower from ferrous citrate ... /than ferrous sulfate, fumarate, gluconate, succinate, glutamate, and lactate/.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1315


This study demonstrated that anticholinergic agents decreased iron absorption in man and animals. Six normal males were given 10 Ci of 59Fe ferrous citrate dissolved in water containing 250 mg of ferrous sulfate after an overnight fast. Whole body counts were done 4 hours later and used as baseline studies. Sixty minutes before the administration of radioiron, the subjects received a dose of 62.5 mg of hexocyclium methosulfate (Tral). The dose was repeated 6 hours later. Four hours after ingestion of radioiron, whole body counting was done. Every 5 days thereafter, for 15 days, a plateau of body radioactivity was reached in all subjects. Percentage absorption was calculated from the final to initial counts, after correction. Similar experiments were done in rats with atropine sulfate. In both experiments, the anticholinergic agent produced a decrease in iron absorption. The effect of atropine persisted when the iron was delivered intragastrically, but not intraduodenally. Another set of experiments showed that iron absorption decreases when radioiron is intraduodenally given in deproteinized acid gastric juice, or in 0.1N HCl, but not when mixed with neutralized gastric juice.

Orrego-Matte H et al; Am J Dige Dis 16 (9): 789-795 (1971)


The uptake of ferrous citrate 59Fe was studied in pregnant rats with or without a 4-dimethylamino-stilben(DS)-induced sarcoma tumor. ... The embryo showed higher concentrations of 59Fe. ... Iron loading only affected the embryo liver. Tumors and the placenta showed a different incorporation of 59Fe.

PMID:3857177 Anghileri LJ et al; Eur J Nucl Med 10 (5-6): 288-9 (1985)


5.4 Mechanism of Action

... Iron loading by 24-hour incubation with 0.36 mmol/L ferric ammonium citrate resulted in a decrease in the activity of nicotinamide adenine dinucleotide (NADH)-cytochrome c oxidoreductase (complex I+III) to 35.3%+/-11.2% of the value in untreated controls; of succinate-cytochrome c oxidoreductase (complex II+III) to 57.4%+/-3.1%; and of succinate dehydrogenase to 63.5%+/-12.6% (p < 0.001 in all cases). The decrease in activity of other mitochondrial enzymes, including NADH-ferricyanide reductase, succinate ubiquinone oxidoreductase (complex II), cytochrome c oxidase (complex IV), and ubiquinol cytochrome c oxidoreductase (complex III), was less impressive and ranged from 71.5%+/-15.8% to 91.5%+/-14.6% of controls. That the observed loss of respiratory enzyme activity was a specific effect of iron toxicity was clearly demonstrated by the complete restoration of enzyme activities by in vitro iron chelation therapy. Sequential treatment with iron and doxorubicin caused a loss of complex I+III and complex II+III activity that was greater than that seen with either agent alone but was only partially correctable by DF treatment. Alterations in cellular adenosine triphosphate measurements paralleled very closely the changes observed in respiratory complex activity.

PMID:9605112 Link G et al; J Lab Clin Med 131 (5): 466-74 (1998)


Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

Ferric Citrate

About the Company : Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-appro...

Biophore, founded in 2007, has established itself as a reliable partner in the development and manufacturing of niche and complex pharmaceutical products. With 4 USFDA and EU-approved API manufacturing facilities, a dedicated intermediate facility, and a R&D laboratory housing 400 scientists, Biophore has positioned itself as a global leader among API companies. It consistently ranks among the top 10 US DMF filers and has obtained over 150 patents worldwide in process and polymorph areas. Biophore's facilities have an impressive track record of successful audits by regulatory bodies such as USFDA, EMEA, ANVISA, COFEPRIS, and WHO GMP.
Biophore

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothTAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Flag Israel
Digital Content Digital Content

Ferric Citrate

About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...

Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, driving progress in the pharmaceutical industry. Leveraging our extensive experience and world-class expertise, we deliver one of the most comprehensive API portfolios in the industry with over 350 Products portfolio. Additionally, we provide tailored CDMO services, harnessing our proficiency in diverse technologies to meet our partners' unique needs, ensuring flexibility and excellence in every project.
TAPI Company Banner

03

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Ex...

Guangzhou Tosun Pharmaceutical was founded in 1999, which mainly focuses on importation & exportation of Active Pharmaceutical Ingrediants, Chemical Raw Materials, Intermediate, Excipients, Herbal extracts, Formulation of Chinese & Western Medicine. With abundant economic strength, the group has successfully developed to a pharmaceutical group enterprise wich intergrets operation of medicine & related products, processing & manufacturing, and importation & exportation together.
blank

04

Hetero Drugs

India
Biotech Digital Meet
Not Confirmed
arrow

Hetero Drugs

India
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs. Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization.
blank

05

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our ...

India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our products are manufactured using premium phosphoric acid and rock phosphate sourced from trusted vendors. We are committed to maintaining high standards in production while offering customization to meet client needs. With a focus on quality and affordability, we continue to serve diverse industries, ensuring reliable and efficient solutions for our customers worldwide.
blank

06

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Jost Chemical Co. is a manufacturer of high purity specialty chemicals for the pharmaceutical, nutritional, food, and other specialty markets. As an FDA registered manufacturer tha...

Jost Chemical Co. is a manufacturer of high purity specialty chemicals for the pharmaceutical, nutritional, food, and other specialty markets. As an FDA registered manufacturer that operates under bulk pharmaceutical cGMP's, Jost Chemical produces high quality chemicals with lot-to-lot consistency that meet USP/EP/ACS/FCC specifications and Kosher and Halal certifications where applicable. Jost Chemical offers a broad line of salts including ascorbates, carbonates, citrates, fumarates, gluconates, lactates, malates, nitrates, phosphates, succinates, sulfates, Ultra Pure Low Heavy Metals and JOSTCOTE® Microencapsulated Products.
blank

07

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Krufren Pharma serves as a reliable partner in research and development (R&D) and manufacturing, dedicated to translating your concepts into impactful solutions and maintaining a c...

Krufren Pharma serves as a reliable partner in research and development (R&D) and manufacturing, dedicated to translating your concepts into impactful solutions and maintaining a competitive edge in advancing healthcare. Under the brand Acuvits, the company offers a range of products addressing diverse therapeutic applications. These include gastrointestinal, cardiovascular, women's healthcare, respiratory, pain management, central nervous system, and treatments for tissue diseases related to neurology, dermatology, and nephrology.
blank

08

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Shreenath Chemicals stands as a prominent producer of bulk drugs, drug intermediates, and fine chemicals. Operating from two advanced manufacturing facilities located in M.I.D.C. T...

Shreenath Chemicals stands as a prominent producer of bulk drugs, drug intermediates, and fine chemicals. Operating from two advanced manufacturing facilities located in M.I.D.C. Tarapur Boisar, Maharashtra, the company boasts audit-friendly units endorsed by numerous global clients. These facilities strictly adhere to international quality standards, holding GMP and ISO 9001:2015 certifications.Established in 1989, Shreenath Chemicals has expanded its services to cater to over 650 Pan-Asian manufacturers of finished formulations and active pharmaceutical ingredient traders, earning high customer satisfaction.
blank

09

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable cont...

Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable contributor in the generic drug industry for Regulatory markets with customer-centric approach since its inception in 2010. To Emerge as a Leading Global Pharmaceutical Company which creates value for all customers by offering excellence in product Quality Standard with committed service and be a significant contributor for global markets.
blank

10

Biotech Digital Meet
Not Confirmed
arrow
arrow
Biotech Digital Meet
Not Confirmed

Ferric Citrate

About the Company : We introduce ourselves as manufacturer of Active Pharmaceutical Ingredients (API) and intermediates with a professional approach that is aimed at finest results. We have etched a r...

We introduce ourselves as manufacturer of Active Pharmaceutical Ingredients (API) and intermediates with a professional approach that is aimed at finest results. We have etched a respectable place in the industry with proven expertise in manufacturing a wide spectrum of products. Vijayasri today is one of the prominent manufacturers of Active Pharmaceutical Ingredients (API) and intermediates. Our excellent Performance in Contract manufacturing over the years has also earned us the status of a trustable name in the pharmaceutical industry.
blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"FERRIC CITRATE","year":"2021","qtr":"Q1","strtotime":1610649000,"product":"FERRIC CITRATE BATCH # 390467 NC5764","address":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI","city":"ANEKAL TALUK,BANGALORE","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"ADLI LOGISTICS","customerCountry":"CANADA","quantity":"52.84","actualQuantity":"52.84","unit":"KGS","unitRateFc":"719.9","totalValueFC":"38516.3","currency":"USD","unitRateINR":53311.126040878116,"date":"15-Jan-2021","totalValueINR":"2816959.9","totalValueInUsd":"38516.3","indian_port":"BANGALORE ICD","hs_no":"29181590","bill_no":"7936188","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE ICD","supplierAddress":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI, ANEKAL TALUK,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"FERRIC CITRATE","year":"2021","qtr":"Q1","strtotime":1610649000,"product":"FERRIC CITRATE BATCH # 390467 NC5769","address":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI","city":"ANEKAL TALUK,BANGALORE","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"ADLI LOGISTICS","customerCountry":"CANADA","quantity":"67.40","actualQuantity":"67.4","unit":"KGS","unitRateFc":"719.9","totalValueFC":"49129.5","currency":"USD","unitRateINR":53311.255637982191,"date":"15-Jan-2021","totalValueINR":"3593178.63","totalValueInUsd":"49129.5","indian_port":"BANGALORE ICD","hs_no":"29181590","bill_no":"7936188","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE ICD","supplierAddress":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI, ANEKAL TALUK,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"FERRIC CITRATE","year":"2021","qtr":"Q1","strtotime":1610649000,"product":"FERRIC CITRATE BATCH # 390467 NF2831","address":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI","city":"ANEKAL TALUK,BANGALORE","supplier":"APOTEX INC","supplierCountry":"INDIA","foreign_port":"TORONTO","customer":"ADLI LOGISTICS","customerCountry":"CANADA","quantity":"57.50","actualQuantity":"57.5","unit":"KGS","unitRateFc":"719.9","totalValueFC":"41913","currency":"USD","unitRateINR":53311.065217391304,"date":"15-Jan-2021","totalValueINR":"3065386.25","totalValueInUsd":"41913","indian_port":"BANGALORE ICD","hs_no":"29181590","bill_no":"7936188","productDescription":"API","marketType":"REGULATED MARKET","country":"CANADA","selfForZScoreResived":"Pharma Grade","supplierPort":"BANGALORE ICD","supplierAddress":"SITE NO.1,BOMMASANDRA INDL.AREA,IVPHASE,JIGANI LINK ROAD,JIGANI HOBLI, ANEKAL TALUK,BANGALORE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"FERRIC CITRATE","year":"2021","qtr":"Q1","strtotime":1614105000,"product":"FERRIC CITRATE (MFG TAX INV NO:DOMESTIC 203\/2020-21 DT:15.02.2021","address":"PLOT #168, PHASE-II, KAMALPURI CLY, SRINAGAR COLONY,","city":"HYDERABAD, AP","supplier":"INAVIR PHARMA TECH ","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"ESKAYEF PHARMACEUTI","customerCountry":"BANGLADESH","quantity":"6.00","actualQuantity":"6","unit":"KGS","unitRateFc":"689.9","totalValueFC":"4096.3","currency":"USD","unitRateINR":49705.833333333336,"date":"24-Feb-2021","totalValueINR":"298235","totalValueInUsd":"4096.3","indian_port":"HYDERABAD AIR","hs_no":"29181590","bill_no":"8892409","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"PLOT #168, PHASE-II, KAMALPURI CLY, SRINAGAR COLONY,, HYDERABAD, AP","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1678127400,"product":"FERRIC CITRATE INN BATCH NO. CI23019 MFG","address":"303\/5, G.I.D.C. ESTATE MAKARPURA","city":"VADODARA GUJARAT.","supplier":"SHANPAR","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"DHAKA BANK LTD","customerCountry":"BANGLADESH","quantity":"25.00","actualQuantity":"25","unit":"KGS","unitRateFc":"57","totalValueFC":"1021.3","currency":"USD","unitRateINR":3360,"date":"07-Mar-2023","totalValueINR":"84000","totalValueInUsd":"1021.3","indian_port":"AHMEDABAD AIR","hs_no":"29181590","bill_no":"8309362","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"AHMEDABAD AIR","supplierAddress":"303\/5, G.I.D.C. ESTATE MAKARPURA, VADODARA GUJARAT.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695753000,"product":"PHARMACEUTICAL RAW MATERIAL: FERRIC CITRATE- BATCH NO. FEC20222307B,BATCH NO: FEC20222308A AND BATCH NO: FEC20222309A(DE","address":"145\/1, JESSORE ROAD,","city":"KOLKATA, W.B.","supplier":"WEST BENGAL CHEMICAL ","supplierCountry":"INDIA","foreign_port":"CHITTAGONG","customer":"STANDARD CHARTERED","customerCountry":"BANGLADESH","quantity":"6000.00","actualQuantity":"6000","unit":"KGS","unitRateFc":"25.6","totalValueFC":"152286.1","currency":"USD","unitRateINR":2106.8333333333335,"date":"27-Sep-2023","totalValueINR":"12641000","totalValueInUsd":"152286.1","indian_port":"Calcutta Sea","hs_no":"29181590","bill_no":"4236872","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Calcutta Sea","supplierAddress":"145\/1, JESSORE ROAD,, KOLKATA, W.B.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1712860200,"product":"FERRIC CITRATE - CONTROL BATCH NO 5509000823 MFG DT DECEMBER 2023 RETEST DT.NOVEMBER 2025","address":"M-34, SAKET,","city":"NEW DELHI,DELHI","supplier":"TAPI TECHNOLOGY & API SERVICES","supplierCountry":"INDIA","foreign_port":"TAIPEI","customer":"BIOPHARM INTERNATIONAL CO.LTD","customerCountry":"TAIWAN","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"445.6","totalValueFC":"807.5","currency":"USD","unitRateINR":33714.345000000001,"date":"12-Apr-2024","totalValueINR":"67428.69","totalValueInUsd":"807.5","indian_port":"Delhi Air","hs_no":"29181590","bill_no":"9080584","productDescription":"API","marketType":"REGULATED MARKET","country":"TAIWAN","selfForZScoreResived":"Pharma Grade","supplierPort":"Delhi Air","supplierAddress":"M-34, SAKET,, NEW DELHI,DELHI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1724092200,"product":"IRON (III) CITRATE HYDRATE (FERRIC CITRATE) CAS.NO.(334024-15-6) - BATCH NO. FC36\/24-25","address":"ROOM NO. 7, ABDUL RASHID CHAWL,","city":"MUMBAI MAHARASHTRA","supplier":"LUMINESCENT CHEMICALS","supplierCountry":"INDIA","foreign_port":"BRUSSELS","customer":"ACROS OITOANLCS BVBA","customerCountry":"BELGIUM","quantity":"50.00","actualQuantity":"50","unit":"KGS","unitRateFc":"25","totalValueFC":"1238.4","currency":"USD","unitRateINR":2077.5,"date":"20-Aug-2024","totalValueINR":"103875","totalValueInUsd":"1238.4","indian_port":"Bombay Air","hs_no":"29181550","bill_no":"3318959","productDescription":"API","marketType":"REGULATED MARKET","country":"BELGIUM","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"ROOM NO. 7, ABDUL RASHID CHAWL,, MUMBAI MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725647400,"product":"PHARMACEUTICAL RAW MATERIALS:FERRIC CITRATE BATCH NO FEC20222404B,FEC20222405C (AS PER INV) UNDER RODTEP","address":"145\/1, JESSORE ROAD,","city":"KOLKATA, W.B.","supplier":"WEST BENGAL CHEMICAL ","supplierCountry":"INDIA","foreign_port":"CHITTAGONG","customer":"TO THE ORDER OF","customerCountry":"BANGLADESH","quantity":"3500.00","actualQuantity":"3500","unit":"KGS","unitRateFc":"24","totalValueFC":"79874.4","currency":"USD","unitRateINR":1912.45,"date":"07-Sep-2024","totalValueINR":"6693575","totalValueInUsd":"79874.4","indian_port":"Calcutta Sea","hs_no":"29181590","bill_no":"3835890","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Calcutta Sea","supplierAddress":"145\/1, JESSORE ROAD,, KOLKATA, W.B.","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1672425000,"product":"F3388-CONF FERRIC CITRATE BIOREAGENT SUITABLE FOR","address":"PLOT.NO.12,BOMMASANDRA-JIGANI LINK ROAD,INDL.AREA,ANEKAL TQ, Contact N","city":"BANGALORE","supplier":"MERCK GROUP","supplierCountry":"UNITED STATES","foreign_port":"NA","customer":"SIGMA ALDRICH CHEMICALS PRIVATE LIMITED","customerCountry":"INDIA","quantity":"5.00","actualQuantity":"5000","unit":"GMS","unitRateFc":"10.8","totalValueFC":"807.5","currency":"INR","unitRateINR":"13.3","date":"31-Dec-2022","totalValueINR":"66541.32","totalValueInUsd":"807.5","indian_port":"BANGALORE AIR","hs_no":"29189990","bill_no":"3992763","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT.NO.12,BOMMASANDRA-JIGANI LINK ROAD,INDL.AREA,ANEKAL TQ, Contact N"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1709317800,"product":"FERRIC CITRATE","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"HANGZHOU PROSERRE CHEMICAL CO LTD","supplierCountry":"CHINA","foreign_port":"HONG KONG","customer":"DR. REDDY\\'S LABORATORIES","customerCountry":"INDIA","quantity":"3.00","actualQuantity":"3","unit":"KGS","unitRateFc":"150","totalValueFC":"454.7","currency":"USD","unitRateINR":"12585","date":"02-Mar-2024","totalValueINR":"37755","totalValueInUsd":"454.7","indian_port":"Hyderabad Air","hs_no":"29181550","bill_no":"2388321","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HONG KONG","supplierAddress":"Room 2002, Sunon Central Mansion, NO.200,Shimin Road,Jianggan District, Hangzhou,Zhejiang, China Hangzhou China","customerAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE"}]
15-Jan-2021
07-Sep-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 23383-11-1 / Ferric Citrate API manufacturers, exporters & distributors?

Ferric Citrate manufacturers, exporters & distributors 1

44

PharmaCompass offers a list of Ferric Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ferric Citrate manufacturer or Ferric Citrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ferric Citrate manufacturer or Ferric Citrate supplier.

PharmaCompass also assists you with knowing the Ferric Citrate API Price utilized in the formulation of products. Ferric Citrate API Price is not always fixed or binding as the Ferric Citrate Price is obtained through a variety of data sources. The Ferric Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ferric Citrate

Synonyms

Iron(iii) citrate, Iron citrate, 3522-50-7, Zerenex, 6043-74-9, 28633-45-6

Cas Number

23383-11-1

Unique Ingredient Identifier (UNII)

63G354M39Z

Ferric Citrate Manufacturers

A Ferric Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferric Citrate, including repackagers and relabelers. The FDA regulates Ferric Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferric Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ferric Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ferric Citrate Suppliers

A Ferric Citrate supplier is an individual or a company that provides Ferric Citrate active pharmaceutical ingredient (API) or Ferric Citrate finished formulations upon request. The Ferric Citrate suppliers may include Ferric Citrate API manufacturers, exporters, distributors and traders.

click here to find a list of Ferric Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ferric Citrate USDMF

A Ferric Citrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ferric Citrate active pharmaceutical ingredient (API) in detail. Different forms of Ferric Citrate DMFs exist exist since differing nations have different regulations, such as Ferric Citrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ferric Citrate DMF submitted to regulatory agencies in the US is known as a USDMF. Ferric Citrate USDMF includes data on Ferric Citrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ferric Citrate USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ferric Citrate suppliers with USDMF on PharmaCompass.

Ferric Citrate JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Ferric Citrate Drug Master File in Japan (Ferric Citrate JDMF) empowers Ferric Citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Ferric Citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Ferric Citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Ferric Citrate suppliers with JDMF on PharmaCompass.

Ferric Citrate WC

A Ferric Citrate written confirmation (Ferric Citrate WC) is an official document issued by a regulatory agency to a Ferric Citrate manufacturer, verifying that the manufacturing facility of a Ferric Citrate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ferric Citrate APIs or Ferric Citrate finished pharmaceutical products to another nation, regulatory agencies frequently require a Ferric Citrate WC (written confirmation) as part of the regulatory process.

click here to find a list of Ferric Citrate suppliers with Written Confirmation (WC) on PharmaCompass.

Ferric Citrate GMP

Ferric Citrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Ferric Citrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferric Citrate GMP manufacturer or Ferric Citrate GMP API supplier for your needs.

Ferric Citrate CoA

A Ferric Citrate CoA (Certificate of Analysis) is a formal document that attests to Ferric Citrate's compliance with Ferric Citrate specifications and serves as a tool for batch-level quality control.

Ferric Citrate CoA mostly includes findings from lab analyses of a specific batch. For each Ferric Citrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Ferric Citrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferric Citrate EP), Ferric Citrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferric Citrate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty